Enanta Pharmaceuticals | ENTA - 当期純利益





当期純利益 変化する 日付
AbbVie USD 4.22B 605M 2026-09
Amgen USD 3.86B 1.49B 2026-09
Anika Therapeutics USD 292K 2.62M 2025-12
Arrowhead Research USD -194.28M 61.55M 2026-06
AstraZeneca USD 3.12B 610M 2026-09
BioCryst Pharmaceuticals USD 78.4M 167.45M 2026-06
Biogen USD 97.5M 222M 2026-06
Bristol-Myers Squibb USD 2.16B 1.16B 2026-09
Enanta Pharmaceuticals USD -22.29M 93.76M 2024-12
Gilead Sciences USD -10.5B 12.52B 2026-06
GlaxoSmithKline GBP 1.54B 1.11B 2026-09
Halozyme Therapeutics USD 247.05M 17.14M 2026-09
Heron Therapeutics USD -2.95M 14.54M 2025-12
Immunic USD -19.3M 6.28M 2025-12
Incyte USD -784.8M 1.37B 2026-09
Insmed USD -13.24M 150.32M 2026-06
Ionis Pharmaceuticals USD -87M 27.65M 2026-09
J&J USD 210M 5.32B 2026-09
Karyopharm Therapeutics USD -22.39M 79.81M 2026-03
Ligand Pharmaceuticals USD -28.48M 76.99M 2026-09
Merck USD 5.07B 6.4B 2026-09
Neurocrine Biosciences USD 206.5M 62.1M 2026-09
Novartis USD 1.2B 2.06B 2026-09
Novavax USD 17.53M 219.91M 2025-12
Pfizer USD 3.24B 3.49B 2026-09
PTC Therapeutics USD 83.5M 86.3M 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sarepta Therapeutics USD -28.46M 23.57M 2026-09
Vertex Pharmaceuticals USD 653.6M 446.2M 2026-09